NEW YORK– Levels, a software company that gives you real-time feedback on how food affects your health, today announced a $38 million Series A alongside a $300 million valuation to continue its mission of solving the metabolic health crisis. The Series A was raised primarily as an operator round, with funding from other founders and operators, including Andrea Funsten (Basecamp Fund), Ben Gilbert and David Rosenthal (Acquired Podcast), Lenny Rachitsky and the Airbnb Alumni Syndicate, Mario Gabriele (The Generalist), Mat Fraser (CrossFit Athlete), and Moshe Lifschitz and Niv Dror (Shrug), as well as a16z, and the Levels member community through a crowdfunding round. To date, Levels has raised $50 million with support from a16z, Trust Ventures, and Shrug Capital.
Earlier this month Levels expanded its suite of holistic member services to include access to in-home blood testing to track metabolic markers and the opportunity to work with a nutritionist during the Levels program. With the close of this round, the company will expand from its current beta community of 25,000 paying members to reach full consumer availability and work toward international expansion later this year.
In line with the company’s goal of building a community to help solve the metabolic health crisis, Levels’ Series A financing included considerable support through a Community Round that was open to all of its early members. More than 1,400 members invested in Levels, reaching the $5 million allowed under crowdfunding regulations in less than six hours. Transparency and openness are core to the company’s values and culture, and the decision to give members the opportunity to invest aligns with Levels’ commitment to building in public, reflecting an effort to embody the value of member-centricity.
“Today, 90% of our $4 trillion in healthcare costs are tied to largely preventable chronic conditions—several downstream from metabolic dysfunction,” says Dr. Casey Means, Levels co-founder and Chief Medical Officer. “A key way we address that is by empowering people with data about their own bodies, so they can take action to live a healthy lifestyle and feel their best. Understanding how our choices affect key health biomarkers in real time—and more broadly understanding our own metabolic health—is foundational for optimal health and longevity.”
Levels co-founder and CEO Sam Corcos adds, “Within the next 5 years, we’re going to be talking about the metabolic-health crisis in the same way that we currently talk about the opioid epidemic and cancer. This is the single biggest health crisis in the world and has yet to penetrate the zeitgeist.”
